| Year |
Citation |
Score |
| 2013 |
Verty AN, Lockie SH, Stefanidis A, Oldfield BJ. Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice. International Journal of Obesity (2005). 37: 279-87. PMID 22473329 DOI: 10.1038/ijo.2012.35 |
0.397 |
|
| 2011 |
Verty AN, Evetts MJ, Crouch GJ, McGregor IS, Stefanidis A, Oldfield BJ. The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1349-58. PMID 21412227 DOI: 10.1038/npp.2011.19 |
0.531 |
|
| 2010 |
Verty AN, Allen AM, Oldfield BJ. The endogenous actions of hypothalamic peptides on brown adipose tissue thermogenesis in the rat. Endocrinology. 151: 4236-46. PMID 20685882 DOI: 10.1210/en.2009-1235 |
0.376 |
|
| 2009 |
Verty AN, Boon WM, Mallet PE, McGregor IS, Oldfield BJ. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). The European Journal of Neuroscience. 29: 2207-16. PMID 19490094 DOI: 10.1111/j.1460-9568.2009.06750.x |
0.708 |
|
| 2009 |
Stefanidis A, Verty AN, Allen AM, Owens NC, Cowley MA, Oldfield BJ. The role of thermogenesis in antipsychotic drug-induced weight gain. Obesity (Silver Spring, Md.). 17: 16-24. PMID 19107124 DOI: 10.1038/oby.2008.468 |
0.304 |
|
| 2009 |
Verty AN, Allen AM, Oldfield BJ. The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. Obesity (Silver Spring, Md.). 17: 254-61. PMID 19057531 DOI: 10.1038/oby.2008.509 |
0.351 |
|
| 2009 |
Verty A, Oldfield B. Evidence for a novel role for the CB2 receptors in the mediation of energy intake and expenditure Appetite. 52: 863. DOI: 10.1016/j.appet.2009.04.200 |
0.332 |
|
| 2007 |
Verty A, Oldfield B. The effect of the cannabinoid receptor antagonist, rimonabant (SR 141716) on energy expenditure. Appetite. 49: 337. DOI: 10.1016/j.appet.2007.03.209 |
0.328 |
|
| 2005 |
Verty AN, McGregor IS, Mallet PE. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology. 49: 1101-9. PMID 16098995 DOI: 10.1016/J.Neuropharm.2005.03.025 |
0.782 |
|
| 2004 |
Singh ME, Verty AN, Price I, McGregor IS, Mallet PE. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology. 47: 1157-69. PMID 15567425 DOI: 10.1016/J.Neuropharm.2004.08.008 |
0.703 |
|
| 2004 |
Singh ME, Verty AN, McGregor IS, Mallet PE. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research. 1026: 244-53. PMID 15488486 DOI: 10.1016/J.Brainres.2004.08.027 |
0.701 |
|
| 2004 |
Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology. 47: 593-603. PMID 15380376 DOI: 10.1016/J.Neuropharm.2004.06.002 |
0.765 |
|
| 2004 |
Verty AN, McGregor IS, Mallet PE. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Research. 1020: 188-95. PMID 15312802 DOI: 10.1016/J.Brainres.2004.06.033 |
0.77 |
|
| 2004 |
Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology. 145: 3224-31. PMID 15033920 DOI: 10.1210/En.2004-0059 |
0.773 |
|
| 2004 |
Verty AN, McGregor IS, Mallet PE. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neuroscience Letters. 354: 217-20. PMID 14700735 DOI: 10.1016/J.Neulet.2003.10.035 |
0.748 |
|
| 2003 |
Verty AN, Singh ME, McGregor IS, Mallet PE. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology. 168: 314-23. PMID 12700881 DOI: 10.1007/S00213-003-1451-9 |
0.734 |
|
| Show low-probability matches. |